Article | 16-October-2019
secretions (e.g., breast milk) and excretions—all originating from the human body. Donated by a human with the goal of benefitting others, these MPHO have indeed saved and improved human lives through their clinical application.
Vigilance is a powerful tool for improving safety and quality. Vigilance includes monitoring and reporting adverse events and outcomes associated with therapeutic treatments. Originating from hemovigilance for blood components, biovigilance is the term used for the monitoring of
Immunohematology, Volume 33 , ISSUE 4, 159–164
Report | 20-March-2020
Anne F. Eder,
Beth A. Dy,
Jean M. Kennedy,
Richard J. Benjamin
Immunohematology, Volume 25 , ISSUE 4, 179–185
Report | 16-March-2020
through the French hemovigilance program, which requires a mandatory report of any transfusion reaction. It has recently been suggested to extend the 10-year restriction in some countries. Considering our experience and observational data, we may consider it safe and efficient to transfuse rare frozen RBC units older than 10 years. An international consensus for RBC cryopreservation time should ideally be established.
Pierre-Yves Le Pennec,
Immunohematology, Volume 25 , ISSUE 1, 13–17